Global Ketorolac Injection Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Ketorolac Injection market size will reach 1,089.67 Million USD in 2025 and is projected to reach 1,326.55 Million USD by 2032, with a CAGR of 2.85% (2025-2032). Notably, the China Ketorolac Injection market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Ketorolac injection is a nonsteroidal anti-inflammatory drug (NSAID) used for the short-term relief of moderate to severe pain. It is often administered intramuscularly or intravenously in hospital or clinical settings. Ketorolac works by inhibiting the production of prostaglandins, which are chemicals involved in inflammation. This medication is particularly useful in situations where oral administration may not be feasible, and rapid pain relief is required, such as postoperative pain, kidney stone pain, or pain related to certain medical procedures. While ketorolac injection provides effective pain management, it is essential to use it for the shortest duration possible due to the potential risks associated with NSAIDs, including gastrointestinal bleeding and kidney problems. As with any medication, it should be prescribed and administered under the guidance of a healthcare professional.
The major global manufacturers of Ketorolac Injection include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals, Athenex, Sichuan Medcalo, Julphar Bangladesh Ltd., Yung Shin Pharm, Tianjin Chase Sun Pharmaceutical, ZISKA Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Ketorolac Injection. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Ketorolac Injection market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Ketorolac Injection market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Ketorolac Injection industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Ketorolac Injection Include:
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Ketorolac Injection Product Segment Include:
Ketorolac Injection 15mg/ml
Ketorolac Injection 30mg/ml
Ketorolac Injection Product Application Include:
Hospital
Clinics
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Ketorolac Injection Industry PESTEL Analysis
Chapter 3: Global Ketorolac Injection Industry Porter's Five Forces Analysis
Chapter 4: Global Ketorolac Injection Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Ketorolac Injection Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Ketorolac Injection Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Ketorolac Injection Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Ketorolac Injection market size will reach 1,089.67 Million USD in 2025 and is projected to reach 1,326.55 Million USD by 2032, with a CAGR of 2.85% (2025-2032). Notably, the China Ketorolac Injection market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Ketorolac injection is a nonsteroidal anti-inflammatory drug (NSAID) used for the short-term relief of moderate to severe pain. It is often administered intramuscularly or intravenously in hospital or clinical settings. Ketorolac works by inhibiting the production of prostaglandins, which are chemicals involved in inflammation. This medication is particularly useful in situations where oral administration may not be feasible, and rapid pain relief is required, such as postoperative pain, kidney stone pain, or pain related to certain medical procedures. While ketorolac injection provides effective pain management, it is essential to use it for the shortest duration possible due to the potential risks associated with NSAIDs, including gastrointestinal bleeding and kidney problems. As with any medication, it should be prescribed and administered under the guidance of a healthcare professional.
The major global manufacturers of Ketorolac Injection include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals, Athenex, Sichuan Medcalo, Julphar Bangladesh Ltd., Yung Shin Pharm, Tianjin Chase Sun Pharmaceutical, ZISKA Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Ketorolac Injection. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Ketorolac Injection market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Ketorolac Injection market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Ketorolac Injection industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Ketorolac Injection Include:
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Ketorolac Injection Product Segment Include:
Ketorolac Injection 15mg/ml
Ketorolac Injection 30mg/ml
Ketorolac Injection Product Application Include:
Hospital
Clinics
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Ketorolac Injection Industry PESTEL Analysis
Chapter 3: Global Ketorolac Injection Industry Porter's Five Forces Analysis
Chapter 4: Global Ketorolac Injection Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Ketorolac Injection Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Ketorolac Injection Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Ketorolac Injection Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Ketorolac Injection Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Ketorolac Injection Product by Type
- 1.2.1 Ketorolac Injection 15mg/ml
- 1.2.2 Ketorolac Injection 30mg/ml
- 1.3 Ketorolac Injection Product by Application
- 1.3.1 Hospital
- 1.3.2 Clinics
- 1.3.3 Others
- 1.4 Global Ketorolac Injection Market Revenue and Sales Analysis
- 1.4.1 Global Ketorolac Injection Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Ketorolac Injection Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Ketorolac Injection Market Sales Price Trend Analysis (2020-2032)
- 1.5 Ketorolac Injection Market Development Status and Trends
- 1.5.1 Ketorolac Injection Industry Development Status Analysis
- 1.5.2 Ketorolac Injection Industry Development Trends Analysis
- 2 Ketorolac Injection Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Ketorolac Injection Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Ketorolac Injection Market Analysis by Country
- 4.1 Global Ketorolac Injection Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Ketorolac Injection Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Ketorolac Injection Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Ketorolac Injection Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Ketorolac Injection Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Ketorolac Injection Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Ketorolac Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Ketorolac Injection Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Ketorolac Injection Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Ketorolac Injection Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Ketorolac Injection Average Sales Price by Manufacturers (2021-2025)
- 5.2 Ketorolac Injection Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Ketorolac Injection Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Ketorolac Injection Market Analysis by Type
- 6.1 Global Ketorolac Injection Market Revenue Analysis by Type
- 6.1.1 Global Ketorolac Injection Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Ketorolac Injection Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Ketorolac Injection Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Ketorolac Injection Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Pfizer
- 7.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Pfizer Ketorolac Injection Product Portfolio
- 7.1.3 Pfizer Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Fresenius Kabi
- 7.2.1 Fresenius Kabi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Fresenius Kabi Ketorolac Injection Product Portfolio
- 7.2.3 Fresenius Kabi Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Fosun Pharma (Gland Pharma)
- 7.3.1 Fosun Pharma (Gland Pharma) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
- 7.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Sagent Pharmaceuticals
- 7.4.1 Sagent Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
- 7.4.3 Sagent Pharmaceuticals Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Hikma
- 7.5.1 Hikma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Hikma Ketorolac Injection Product Portfolio
- 7.5.3 Hikma Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Lunan Pharma
- 7.6.1 Lunan Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Lunan Pharma Ketorolac Injection Product Portfolio
- 7.6.3 Lunan Pharma Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Alvogen
- 7.7.1 Alvogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Alvogen Ketorolac Injection Product Portfolio
- 7.7.3 Alvogen Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Chengdu Brilliant Pharmaceuticals
- 7.8.1 Chengdu Brilliant Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
- 7.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Athenex
- 7.9.1 Athenex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Athenex Ketorolac Injection Product Portfolio
- 7.9.3 Athenex Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Sichuan Medcalo
- 7.10.1 Sichuan Medcalo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Sichuan Medcalo Ketorolac Injection Product Portfolio
- 7.10.3 Sichuan Medcalo Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Julphar Bangladesh Ltd.
- 7.11.1 Julphar Bangladesh Ltd. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
- 7.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 Yung Shin Pharm
- 7.12.1 Yung Shin Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Yung Shin Pharm Ketorolac Injection Product Portfolio
- 7.12.3 Yung Shin Pharm Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.13 Tianjin Chase Sun Pharmaceutical
- 7.13.1 Tianjin Chase Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
- 7.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.14 ZISKA Pharmaceuticals
- 7.14.1 ZISKA Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
- 7.14.3 ZISKA Pharmaceuticals Ketorolac Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Ketorolac Injection Industry Chain Analysis
- 8.2 Ketorolac Injection Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Ketorolac Injection Product Downstream Application Analysis
- 8.3.1 Global Ketorolac Injection Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Ketorolac Injection Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Ketorolac Injection Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Ketorolac Injection Typical Downstream Customers
- 8.5 Ketorolac Injection Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
